CHRS

CHRS

USD

Coherus BioSciences Inc. Common Stock

$1.550-0.010 (-0.641%)

Precio en Tiempo Real

Healthcare
Biotecnología
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$1.560

Máximo

$1.590

Mínimo

$1.390

Volumen

1.14M

Fundamentos de la Empresa

Capitalización de Mercado

180.2M

Industria

Biotecnología

País

United States

Estadísticas de Negociación

Volumen Promedio

1.23M

Bolsa

NGM

Moneda

USD

Rango de 52 Semanas

Mínimo $0.66Actual $1.550Máximo $2.43

Noticias Relacionadas

GlobeNewswire

Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025

REDWOOD CITY, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ:CHRS), today announced that its third quarter 2025 financial results will be released after market close on Thursday, November 6,

Ver más
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025
GlobeNewswire

Coherus Oncology to Participate in Upcoming Investor Conferences

REDWOOD CITY, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc. (NASDAQ:CHRS) today announced that the company will be webcasting its presentations at the following upcoming conferences: UBS Global

Ver más
Coherus Oncology to Participate in Upcoming Investor Conferences